Based on these findings, we hypothesized that JAK2 inhibition could ameliorate neurodegeneration in ALS model mice by inhibiting harmful inflammatory processes in microglia/macrophages. The gene discussed is JAK2; the disease is amyotrophic lateral sclerosis.